Sartorius announces offer to acquire TAP
Sartorius Stedim Biotech made a cash offer to acquire the UK company TAP Biosystems Group plc (TAP Biosystems) through its wholly owned subsidiary Sartorius Stedim Biotech GmbH. The proposed transaction, which is subject to customary closing conditions, including the approval of TAP’s shareholders, values the equity of TAP Biosystems at approximately €33 million. The transaction has been unanimously approved by the boards of directors of both companies and is expected to close at the end of 2013.
Most read news
Organizations
Other news from the department business & finance
Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Observing nanoparticles with unprecedented precision - Illuminated: Researchers investigate new physical phenomena on the nanoscale with microstructured fibers
High-throughput drug screening in 3D
Stanford Scientists Pinpoint Key Proteins in Blood Stem Cell Replication
Chickens and pigs with integrated genetic scissors - Genome editing in farm animals
X-rays show birth of semiconductor for blue LEDs - Gallium nitride is the second most important semiconductor material after silicon
Sartorius Stedim Biotech and Refine Technology Announce Cooperation